Drug intelligence / Profile preview

HCU EASY

Development stage: Unknown
Lead developer: Galen
Administration: Oral

Overview

HCU EASY is a medical nutrition product (medical food) developed by POA Pharma (a subsidiary of Galen) for the dietary management of homocystinuria (HCU). It is a methionine-free protein substitute available in tablet form, specifically designed for patients aged 3 years and older. The formulation provides essential and non-essential amino acids (excluding methionine), along with vitamins, minerals, and trace elements. By providing a source of protein that does not contribute to methionine intake, HCU EASY helps manage the accumulation of methionine and its metabolite homocysteine, which are toxic in individuals with HCU. It is intended for use under strict medical supervision as part of a methionine-restricted diet and is not intended as a sole source of nutrition.

Brand names: HCU EASY
Other names: HCU EASY-POA Pharma

Beyond the preview

Go deeper on HCU EASY.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on HCU EASY.

Explore the full profile